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Given the complex interactions between dopamine D1 and
glutamate NMDA receptors in the striatum, we investigated the
role of these receptors in transporter-mediated GABA release
from cultured medium spiny neurons of rat striatum. Like NMDA
receptor-mediated [3H]-GABA release, that induced by pro-
longed (20 min) dopamine D1 receptor activation was en-
hanced on omission of external calcium, was action potential-
independent (tetrodotoxin-insensitive), and was diminished by
the GABA transporter blocker nipecotic acid, indicating the
involvement of transporter-mediated release. Interestingly, low-
ering the external sodium concentration only reduced the stim-
ulatory effect of NMDA. Blockade of Na1/K1-ATPase by
ouabain enhanced NMDA-induced but abolished dopamine-
induced release. Moreover, dopamine appeared to potentiate
the effect of NMDA on [3H]-GABA release. These effects of
dopamine were mimicked by forskolin. m-Opioid receptor-
mediated inhibition of adenylyl cyclase by morphine reduced
dopamine- and NMDA-induced release. These results confirm
previous studies indicating that NMDA receptor activation
causes a slow action potential-independent efflux of GABA by
reversal of the sodium-dependent GABA transporter on sodium
entry through the NMDA receptor channel. Moreover, our data
indicate that activation of G-protein-coupled dopamine D1 re-
ceptors also induces a transporter-mediated increase in spon-
taneous GABA release, but through a different mechanism of
action, i.e., through cAMP-dependent inhibition of Na1/K1-
ATPase, inducing accumulation of intracellular sodium, reversal
of the GABA carrier, and potentiation of NMDA-induced re-
lease. These receptor interactions may play a crucial role in the
behavioral activating effects of psychostimulant drugs.
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In the striatum, dopamine D1 and NMDA receptors display
complex interactions regulating the activity of efferent striatal
neurons (Cepeda and Levine, 1998). Mesencephalic dopamine
and limbic glutamate projections play a critical role in multiple
brain functions, including psychomotor activity and reward-
related incentive learning (Robbins and Everitt, 1996; Pierce and
Kalivas, 1997; Kelley, 1999). Changes in the functioning of these
neuronal systems have been implicated in various neurological
and psychiatric disorders, such as Parkinsonism, schizophrenia,
and drug abuse (Albin et al., 1989; Knable and Weinberger, 1997;
Koob and Le Moal, 1997). Therefore, it is of interest to elucidate
the mechanisms by which dopamine and glutamate, acting on
their respective receptors, produce their biological effects on
target neurons.
In the striatum, the major targets of released dopamine and
glutamate are the GABAergic medium spiny neurons, which
represent the predominant type of efferent and recurrent neurons
in this brain region (Smith and Bolam, 1990; Di Chiara et al.,
1994). It is intriguing that in neurons that display fast action
potential-induced exocytotic GABA release, prolonged NMDA
receptor activation may cause a delayed and nonvesicular release
of GABA (for review, see Attwell et al., 1993). There is strong
evidence that this delayed release of GABA from the cytoplasmic
pool in neurons is caused by entry of sodium ions through the
NMDA receptor channel, resulting in accumulation of sodium at
the GABA transporter and reversal of the direction of sodium-
dependent GABA transport (Erecı´nska, 1987; Weiss, 1988; Ber-
nath and Zigmond, 1990; Dunlop et al., 1991; Belhage et al., 1993;
Duarte et al., 1993; Breukel et al., 1998). The physiological
significance of neurotransmitter-induced nonvesicular GABA re-
lease is indicated by the fact that amphetamine, which strongly
enhances striatal glutamate and dopamine levels, may cause
carrier-mediated GABA release from glial cells and/or neurons
in the striatum of freely moving rats (Del Arco et al., 1998).
In striatal medium spiny neurons, activation of dopamine D1
receptors enhances the activity of cAMP-dependent protein ki-
nase (PKA), mediating phosphorylation of numerous proteins,
including NMDA receptors (Snyder et al., 1998), sodium chan-
nels (Schiffmann et al., 1995), and Na1/K1-ATPase (Bertorello
et al., 1990; Fienberg et al., 1998). Moreover, the striatal GABA
transporter protein is inhibited by PKA activation (Tian et al.,
1994). Therefore, we investigated (1) whether activation of
G-protein-coupled dopamine D1 receptors, like activation of
NMDA receptors, may cause transporter-mediated increase in
spontaneous GABA release from rat striatal medium spiny neu-
rons, (2) the mechanisms underlying receptor-regulated GABA
release, and (3) the interactions between dopamine D1, NMDA,
and m-opioid receptors in this action potential-independent re-
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lease. In view of the highly complex interactions between dopa-
mine D1 and NMDA receptors in the striatum and because both
neurons and glial cells determine extracellular GABA levels, we
primarily studied these issues in neuronal cultures of rat striatum,
which consisted of ;95% of GABA neurons (Bockaert et al.,
1986; Weiss, 1988; Van Vliet et al., 1991; Schoffelmeer et al.,
1997).
MATERIALS AND METHODS
Superfusion of brain slices. All experiments were approved by the Animal
Care Committee of the Free University of Amsterdam. Male Wistar rats
(160–200 gm body weight; Harlan, Zeist, The Netherlands) were decap-
itated, and nucleus accumbens or caudate putamen slices (0.3 3 0.3 3 1
mm) were prepared using a McIlwain tissue chopper, then incubated
with radiolabeled GABA, and superfused essentially as described pre-
viously (Schoffelmeer et al., 1988). In short, slices were washed twice
with 5 ml Krebs-Ringer’s bicarbonate medium containing (in mM): 121
NaCl, 1.87 KCl, 1.17 KHPO4, 25 NaHCO3, 10 D-(1)-glucose, pH 7.4,
and (except in experiments in Fig. 1) 1.2 CaCl2 and subsequently
incubated for 15 min in this medium, containing 0.1 mM [ 3H]-GABA
under an atmosphere of 95% O2–5% CO2 at 37°C. After labeling, the
slices were washed and transferred to each of 24 chambers of a super-
fusion apparatus (;3 mg tissue per chamber; 0.2 ml volume) and super-
fused (0.25 ml/min) with medium gassed with 95% O2–5% CO2 at 37°.
The GABA transaminase inhibitor amino-oxyacetic acid (10 mM) was
present throughout the experiments to inhibit [ 3H]-GABA degradation.
The superfusate was collected as 10 min samples after 40 min of
superfusion (t 5 40 min). Neurotransmitter release was induced during
superfusion by exposing the slices to medium containing dopamine or
NMDA for 20 min at t 5 50 min. In each experiment, quadruplicate
observations were made.
Primary cultures of striatal neurons. To investigate the regulation of
GABA release by dopamine D1, m-opioid, and NMDA receptors in
striatal neurons, primary neuronal cultures were prepared as described
previously (Van Vliet et al., 1991; Schoffelmeer et al., 1997). Briefly, the
striatum (caudate/putamen 1 nucleus accumbens) was dissected from
17-d-old rat embryos and dissociated mechanically using a fine-narrowed
Pasteur pipette in serum-free medium. Cells were plated in 12-well
Linbro culture dishes (6 3 10 5 cells per milliliter per well) that were
coated with poly-L-ornithine (1.5 mg/ml) and medium containing 10%
supplemented calf serum. The culture medium was composed of a 1:1
mixture of DMEM and F-14 nutrient mixture and contained glucose
(0.6%), glutamine (2 nM), sodium bicarbonate (3 mM), HEPES (5 mM),
streptomycin (100 mg/ml), and penicillin (100 IU/ml). A defined hor-
mone and salt mixture was added that consisted of insulin (25 mg/ml),
transferrin (100 mg/ml), putrescine (60 mM), b-estradiol (1 pM), and
selenium sodium salt (30 nM). Under these culture conditions, the neu-
rons develop an extensive matrix of dendrites and synapses during the
first week in culture and are all positive after immunocytochemical
staining with antibodies against GABA or GAD. Moreover, because the
neurons grow in a serum-free hormone-supplemented medium, only few
glial cells (,5%) are observed [for further details, see Bockaert et al.
(1986) and Van Vliet et al. (1991)]. After 8 d in vitro, the neurons were
washed with 2 ml PBS containing (in mM): 137 NaCl, 2.7 KCl, 1.2 CaCl2,
0.5 MgCl2, 8 Na2HPO4, 1.5 KH2PO4, 5 glucose, pH 7.3, at 37°C, and
subsequently exposed to 2 ml PBS containing 0.1 mM [ 3H]-GABA. Each
dish was washed extensively after 30 min by changing the 2 ml PBS every
4 min. Seven changes of medium (time needed to reach a steady state of
tritium outflow) were followed by stimulation of the neurons in the
absence or presence of drugs for 20 min. Amino-oxyacetic acid (10 mM)
was present throughout the experiments. Quadruplicate observations
were made in each experiment.
Calculation of release data. To determine neurotransmitter release
from superfused striatal slices, the radioactivity remaining at the end of
the superfusion experiment was extracted from the tissue with 0.1N HCl.
The radioactivity in superfusion fractions and tissue extracts was deter-
mined by liquid scintillation counting. The efflux of radioactivity during
each collection period was expressed as a percentage of the amount of
radioactivity in the slices at the beginning of the respective collection
period. The NMDA- and dopamine-induced release of neurotransmitter
was calculated by subtracting the spontaneous efflux of radioactivity from
the total overflow of radioactivity during stimulation and the following 20
min. Because the release of the neurotransmitters was returned to basal
levels during the next 10 min period, a linear decline from the 10 min
interval before to that 40–50 min after the onset of stimulation was
assumed for calculation of the spontaneous efflux of radioactivity. The
spontaneous efflux of radioactivity from nucleus accumbens and caudate
putamen slices amounted to 3.4 6 0.2 and 3.2 6 0.1% of total tissue
radioactivity, respectively. The evoked release was expressed as percent-
age of the content of radioactivity of the slices at the start of the
stimulation period.
To determine [ 3H]-GABA release from cultured striatal neurons, the
2 ml of medium was collected after the 20 min stimulation period, and
[ 3H] remaining in the cells was extracted with 1 ml 0.1N HCl. Radioac-
tivity in the media and tissue extracts was determined by liquid scintil-
lation counting. [ 3H]-GABA release from the neurons was expressed as
the radioactivity found in the stimulation media as percentage of total
radioactivity present in the media and tissue extracts. Evoked neuro-
transmitter release during the 20 min stimulation period was determined
by subtracting release in the absence of stimulatory agents from that
found in their presence. The spontaneous efflux of radioactivity from the
neurons during the stimulation period amounted to 3.5 6 0.2% of total
radioactivity.
The effects of drugs were analyzed using one-way ANOVAs, followed
by Student–Newman–Keuls tests where appropriate.
Materials. [ 3H]-GABA (57 Ci/mmol) was purchased from the Radio-
chemical Center (Amersham, UK). NMDA, dopamine, naloxone, fors-
kolin, 1,9-dideoxyforskolin, tetrodotoxin (TTX), ouabain, nipecotic acid,
poly-L-ornithine, streptomycin, penicillin, insulin, transferrin, putrescine,
b-estradiol, dexamethasone 21-phosphate, and aldosterone 21-acetate
were obtained from Sigma (St. Louis, MO); DMEM and F-12 nutrient
mixture and fetal calf serum were from Life Technologies (Paisley, UK);
and HEPES, glucose, glutamine, sodium carbonate, and selenium
sodium salt were from Merck (Darmstadt, FRG). Morphine hydrochlo-
ride was obtained from O.P.G. (Utrecht, The Netherlands). SCH23390
and R(2)-2 amino-5-phosphonovaleric acid (AP-5) was from RBI
(Natick, MA).
RESULTS
Interacting dopamine D1 and NMDA receptors
differentially enhance transporter-mediated GABA
release from striatal neurons
Preliminary experiments revealed that exposure of superfused
rat striatal slices to dopamine or NMDA caused a delayed in-
crease in [3H]GABA efflux (as opposed to rapid action potential-
dependent release), reaching a maximum 10–20 min after drug
exposure [for discussion, see Belhage et al. (1993)]. Exposure of
nucleus accumbens or caudate putamen slices for 20 min to a
(submaximally effective) concentration of dopamine or NMDA
(30 mM) only slightly enhanced the efflux of [3H]-GABA when 1.2
mM calcium was present in the medium. As shown in Figure 1,
lowering the external calcium concentration caused a profound
increase in the stimulatory effects of dopamine and NMDA,
indicating the occurrence of nonexocytotic neurotransmitter re-
lease. To investigate this phenomenon at the level of GABA
neurons in more detail, we investigated whether this delayed
calcium-independent release of GABA after dopamine or
NMDA exposure is also apparent in primary cultures of striatal
medium spiny neurons at 8 d in vitro (i.e., after maturation of
GABA neurons). Indeed, the inverse relationship between the
external calcium concentration and dopamine- or NMDA-
induced [3H]-GABA efflux was also found to occur in cultured
GABA neurons (Fig. 1). In these cultured neurons, dopamine-
and NMDA-induced release (in excess of basal efflux) could be
reliably measured on 20 min exposure to dopamine or NMDA
even in the presence of 1.2 mM calcium, amounting to ;3 and 7%
of total radioactivity, respectively. Therefore, subsequent exper-
iments were performed in the presence of calcium, allowing us to
study the GABA release mechanism under (quasi) physiological
conditions. Figure 2 shows that dopamine and NMDA enhanced
[ 3H]-GABA release in striatal cultures in a concentration-
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dependent manner. Moreover, although 30 mM NMDA-evoked
release was inhibited by the selective NMDA receptor antagonist
AP-5, that induced by 30 mM dopamine was reduced by the
selective dopamine D1 receptor antagonist SCH23390, indicating
the involvement of NMDA and D1 receptors. As might be ex-
pected, AP-5 (100 mM) and SCH23390 (0.1 mM) did not alter
[ 3H]-GABA release induced by dopamine and NMDA,
respectively.
Exposure of the neurons to 30 mM nipecotic acid, a selective
blocker of the GABA transporter, caused an almost fourfold
increase in spontaneous [3H]-GABA efflux and completely pre-
vented NMDA and dopamine receptor-stimulated [3H]-GABA
release, whereas blockade of voltage-gated sodium channels with
1 mM TTX was ineffective in this respect (Fig. 3). Therefore,
[ 3H]-GABA release appears to be transporter-mediated and does
not seem to involve calcium-dependent exocytotic release. Re-
placement of sodium chloride by choline chloride (causing a
;3.5-fold increase in spontaneous efflux of the neurotransmitter)
strongly reduced NMDA-induced release, leaving that induced
by dopamine unchanged (Fig. 3). Accordingly, dopamine D1
receptor-mediated release (unlike NMDA receptor-mediated re-
lease) does not appear to be caused by an inward transmembrane
sodium influx.
Pharmacological inhibition of outward sodium transport by the
Na1/K1-ATPase inhibitor ouabain (10 mM) induced a similar
increase in [ 3H]-GABA release as 30 mM dopamine. Interestingly,
Figure 1. Role of external calcium on NMDA- and
dopamine-evoked release of [ 3H]-GABA from su-
perfused slices of rat nucleus accumbens and cau-
date putamen and from cultured striatal GABA neu-
rons. Brain slices and cultured neurons were exposed
to NMDA or dopamine (DA) for 20 min. Neuro-
transmitter release was calculated as percentage of
total radioactivity in excess of spontaneous efflux.
Data represent means 6 SEM of 12 observations.
Quadruplicate observations were made per experi-
ment. *p , 0.001 as compared with values in the
absence of calcium (Student–Newman–Keuls).
Figure 2. Dose-dependent stimulation of [ 3H]-GABA release from cul-
tured striatal GABA neurons by NMDA and dopamine and its inhibition
by receptor selective antagonists. The neurons were exposed to NMDA or
dopamine (DA) for 20 min. The NMDA receptor antagonist AP-5 and
the dopamine D1 receptor antagonist SCH23390 were present 20 min
before and during exposure to NMDA or dopamine. Neurotransmitter
release was calculated as percentage of total radioactivity in excess of
spontaneous efflux. The antagonists alone did not change spontaneous
efflux of radioactivity. Data represent means 6 SEM of 12 observations.
Quadruplicate observations were made per experiment.
Figure 3. Effect of nipecotic acid, tetrodotoxin, and reduction of the
external sodium concentration on NMDA- and dopamine-evoked [ 3H]-
GABA release from cultured striatal neurons. The neurons were exposed
to NMDA or dopamine (DA) for 20 min. The GABA transporter blocker
nipecotic acid (NIP, 30 mM), the sodium channel blocker tetrodotoxin
(TTX, 1 mM), and the medium with sodium chloride replaced by choline
chloride were present 20 min before and during NMDA or dopamine
exposure. Neurotransmitter release was calculated as percentage of total
radioactivity in excess of spontaneous efflux. TTX alone did alter spon-
taneous efflux. Nipecotic acid and exposure to low sodium medium en-
hanced spontaneous [ 3H]-GABA efflux from 3.3 6 0.2 to 12.4 6 0.3 and
11.6 6 0.2%, respectively. Data represent means 6 SEM of 12–16 obser-
vations. Quadruplicate observations were made per experiment. *p ,
0.001 as compared with control values (Student–Newman–Keuls).
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ouabain strongly potentiated NMDA-induced release and dimin-
ished that induced by dopamine (Fig. 4). At a higher concen-
tration of ouabain (100 mM), causing a ;3.5-fold increase in
[3H]-GABA efflux, NMDA-induced neurotransmitter release
amounted to no less than 36% of total tissue content, whereas
that induced by dopamine was abolished (data not shown). These
data strongly suggest that dopamine-induced release is caused by
(partial) inhibition of the sodium pump. As might then be ex-
pected, exposure of striatal neurons to dopamine potentiated
NMDA-induced [3H]-GABA release (Fig. 5). Such a synergistic
interaction between dopamine D1 and NMDA receptors was also
observed when calcium was omitted from the medium.
Dopamine D1 and m-opioid receptors regulate
transporter-mediated GABA release in a
cAMP-dependent manner
Exposure of striatal neurons to the adenylyl cyclase activator
forskolin (10 mM) mimicked the effect of dopamine D1 receptor
activation on [3H]-GABA release, whereas the inactive enantio-
mer 1,9-dideoxyforskolin did not affect neurotransmitter efflux
(Fig. 6). Like dopamine, forskolin appeared to potentiate
NMDA-induced [3H]-GABA release. Moreover, forskolin did
not further enhance neurotransmitter release on inhibition of
Na1/K1-ATPase by 10 mM ouabain. Figure 6 also shows that
dopamine (unlike NMDA) no longer enhanced neurotransmitter
release when the neurons were simultaneously exposed to fors-
kolin. Activation of m-opioid receptors, inhibitorily coupled to
adenylyl cyclase in these neurons (Van Vliet et al., 1991), by 10
mM morphine caused a naloxone-reversible inhibition of NMDA-
and dopamine-induced [3H]-GABA release (Figs. 7, 8). These
inhibitory effects were blocked by forskolin, indicating the in-
volvement of a cAMP-dependent mechanism.
DISCUSSION
The release of biogenic amines, such as dopamine and noradren-
aline, in the brain on activation of NMDA receptors is action
potential-mediated (tetrodotoxin sensitive) and completely de-
pendent on the presence of extracellular calcium, involving exo-
cytotic release from a vesicular pool (Wang et al., 1992; Malva et
al., 1994). However, the neurotransmitter GABA, found in vesi-
cles as well as in the cytosol of GABAergic forebrain neurons
(Maycox et al., 1990), is released not only by exocytosis on arrival
of an action potential but also in an action potential-independent
nonvesicular fashion, which may even predominate after pro-
longed activation of NMDA receptors. Studies on the nature of
this NMDA-induced mechanism in olfactory (Jaffe and Vaello,
1988), striatal (Weiss, 1988), cortical (Belhage et al., 1993), and
hippocampal (Breukel et al., 1998) neurons as well as in chick
retina cells (Duarte et al., 1993) have shown that this is caused by
reversal of GABA transporter, driven by the electrochemical
sodium gradient, on sodium entry through the NMDA receptor
channel (for review, see Attwell et al., 1993). Moreover, the
activity of the GABA transporter appeared to be reduced by
external calcium (Bernath and Zigmond, 1990; Duarte et al.,
1993). The inverse relationship between the activity of the GABA
transporter and external calcium is most likely attributable to the
activity of the Na1/Ca21-exchanger, promoting calcium efflux in
exchange for sodium (Blaustein et al., 1991; Duarte et al., 1993).
This nonexocytotic increase in spontaneous GABA efflux may
represent a continuous release mechanism that occurs far from
the active zones (e.g., at the level of neuronal cell bodies) (Bel-
hage et al., 1993; Duarte et al., 1993). Because NMDA receptor-
mediated nonexocytotic GABA efflux may actually be a major
effect of glutamate on central GABA neurons even in the pres-
ence of calcium and was recently shown to occur in rat striatum
in vivo (Del Arco et al., 1998), it seems to represent a physiolog-
ical phenomenon rather than the result of artificial stimulatory
conditions (Sihra and Nichols, 1987). However, it was unknown
until now whether this action potential-independent release
mechanism is also regulated by neurotransmitters other than
Figure 4. Effect of blockade of Na 1/K 1-ATPase on [ 3H]-GABA release
from cultured striatal GABA neurons and its stimulation by NMDA or
dopamine. The neurons were exposed to the sodium pump inhibitor
ouabain (OUAB, 10 mM) and/or NMDA (30 mM) or dopamine (DA, 30
mM) for 20 min. Neurotransmitter release was calculated as percentage of
total radioactivity in excess of spontaneous efflux. Data represent
means 6 SEM of 12–16 observations. Quadruplicate observations were
made per experiment. *p , 0.001 as compared with values in the presence
of ouabain or NMDA alone (Student–Newman–Keuls).
Figure 5. Synergistic stimulatory effect of NMDA and dopamine on
[ 3H]-GABA release from cultured striatal GABA neurons. The neurons
were exposed to NMDA (30 mM) and/or dopamine (DA, 30 mM) for 20
min. Neurotransmitter release was calculated as percentage of total ra-
dioactivity in excess of spontaneous efflux. Data represent means 6 SEM
of 24 observations obtained in six separate experiments. *p , 0.01 as
compared with the sum of NMDA- and dopamine-evoked release
(Student–Newman–Keuls).
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glutamate, such as those activating stimulatory and inhibitory
G-protein-coupled receptors.
In agreement with the involvement of nonexocytotic GABA
release, our present study shows that [3H]-GABA efflux in cul-
tured striatal neurons (as in striatal slices) on prolonged NMDA
receptor activation is inversely related to the external calcium
concentration. Moreover, NMDA-induced release was strongly
reduced on lowering the external sodium concentration (i.e.,
dependent on the electrochemical sodium gradient), unchanged
by blockade of voltage-gated sodium channels with tetrodotoxin
(i.e., independent of action potentials), and virtually abolished by
the selective GABA transporter nipecotic acid as shown by others
(see above). Accordingly, blockade of outward sodium transport
after inhibition of Na1/K1-ATPase by ouabain strongly en-
hanced NMDA-induced GABA efflux.
Although dopamine D1 receptors in striatal medium spiny
neurons are well known to be inhibitorily linked to voltage-gated
sodium and calcium channels (Surmeier et al., 1992, 1995; Ce-
peda and Levine, 1998; Schiffmann et al., 1995; Zhang et al.,
1998), dopamine D1 receptor activation appeared to enhance
rather than reduce [3H]-GABA efflux from cultured striatal neu-
rons (as observed in slices of rat striatum). Like NMDA-induced
[ 3H]-GABA efflux, that evoked by dopamine appeared to be
reduced by external calcium and to be diminished on blockade of
Figure 6. Effect of activation of adenylyl cyclase by forskolin
on [ 3H]-GABA release from cultured striatal GABA neu-
rons and its stimulation by NMDA, dopamine, and ouabain.
The neurons were exposed to NMDA (30 mM), dopamine
(30 mM), ouabain (10 mM), and/or forskolin (FORSK, 10 mM)
or 1,9-dideoxyforskolin (1,9-DD-FORSK, 10 mM) for 20 min.
Neurotransmitter release was calculated as percentage of
total radioactivity in excess of spontaneous efflux. Data rep-
resent means of 12–16 observations. Quadruplicate obser-
vations were made per experiment. *p , 0.01 as compared
with the sum of NMDA- and forskolin-evoked release
(Student–Newman–Keuls).
Figure 7. m-Opioid receptor-mediated inhibition of NMDA-evoked
[ 3H]-GABA release from cultured striatal GABA neurons and its reversal
by forskolin. The neurons were exposed to NMDA or NMDA 1 forskolin
(FORSK, 10 mM) for 20 min. The m-opioid receptor agonist morphine
(MORPH, 10 mM) or the antagonist naloxone (NAL, 1mM) or both were
present 20 min before and during stimulation. Neurotransmitter release
was calculated as percentage of total radioactivity in excess of spontane-
ous efflux. Data represent means 6 SEM of 12 observations. Quadrupli-
cate observations were made per experiment. *p , 0.01 as compared with
control values (Student–Newman–Keuls).
Figure 8. m-Opioid receptor-mediated inhibition of dopamine-evoked
[ 3H]-GABA release from cultured striatal GABA neurons and its reversal
by forskolin. The neurons were exposed to dopamine (DA) or dopamine
1 forskolin (FORSK, 10 mM) for 20 min. The m-opioid receptor agonist
morphine (MORPH, 10 mM) or the antagonist naloxone (NAL, 1 mM) or
both were present 20 min before and during stimulation. Neurotransmit-
ter release was calculated as percentage of total radioactivity in excess of
spontaneous efflux. Data represent means 6 SEM of 12 observations.
Quadruplicate observations were made per experiment. *p , 0.01 as
compared with control values (Student–Newman–Keuls).
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the GABA transporter with nipecotic acid. Therefore, dopamine-
induced release also seems to be caused by reversal of the GABA
transporter. Nevertheless, dopamine D1 receptor-mediated [3H]-
GABA efflux differed from that induced by NMDA receptor
activation in that (1) it was unaffected by lowering the external
sodium concentration and (2) completely blocked by ouabain.
The finding that lowering the external sodium concentration did
not reduce the effect of dopamine is not surprising because
dopamine D1 receptor activation in striatal medium spiny neu-
rons is not associated with an increase of transmembrane sodium
entry. On the other hand, the finding that ouabain completely
prevented the stimulatory effect of dopamine on [3H]-GABA
efflux, whereas it strongly enhanced the effect of NMDA, indi-
cates that dopamine D1 receptor activation may cause [3H]-
GABA release through (partial) inhibition of Na1/K1-ATPase.
Accordingly, activation of dopamine D1 receptors may be ex-
pected to lead to a slow accumulation of intracellular sodium ions,
thereby reducing the transmembrane electrochemical gradient of
sodium. Indeed, it has been well established that dopamine D1
receptor activation in isolated striatal medium spiny neurons
causes inhibition of ouabain-sensitive Na1/K1-ATPase in a
cAMP/PKA-dependent manner (Bertorello et al., 1990; Fienberg
et al., 1998). In agreement with such a mechanism of action,
dopamine D1 receptor activation potentiated sodium-dependent
NMDA-induced [3H]-GABA efflux. The cAMP/PKA-dependence
of these effects of dopamine is indicated by the fact that activation
of adenylyl cyclase by forskolin mimicked the effect of dopamine
on [3H]-GABA efflux, potentiated the stimulatory effect of
NMDA, and prevented a further increase of neurotransmitter
release by dopamine. Moreover, just like the stimulatory effect of
dopamine, that of forskolin was abolished when Na1/K1-
ATPase was inhibited. In addition, activation of m-opioid recep-
tors, previously shown to be inhibitorily coupled to adenylyl
cyclase in striatal slices and cultured medium spiny neurons
(Schoffelmeer et al., 1988; Van Vliet et al., 1991), inhibited
NMDA- and dopamine-stimulated [3H]-GABA efflux, and this
inhibitory effect was prevented by forskolin.
Because forskolin (unlike the inactive enantiomer 1,9-
dideoxyforskolin) blocked the effect of dopamine on carrier-
mediated neurotransmitter efflux, the involvement of phospho-
lipase C-coupled dopamine D1 receptors (Chergui and Lacey,
1999) is unlikely. Accordingly, it was demonstrated recently that
dopamine D1 receptor-mediated inhibition of Na1/K1-ATPase
in rat striatal neurons is independent of the stimulatory effect of
dopamine on phospholipid-dependent protein kinase (PKC)
(Nishi et al., 1999). In addition, the observation that dopamine
potentiated rather than inhibited NMDA-induced [3H]-GABA
efflux indicates that the effect of D1 receptor activation does not
involve cAMP-dependent phosphorylation of the GABA trans-
porter inhibiting GABA reuptake at the level of striatal nerve
terminals (Tian et al., 1994).
Taken together, our present data indicate that dopamine D1
and NMDA receptors differentially mediate an accumulation of
intracellular sodium in striatal medium spiny neurons, causing
nonvesicular GABA transporter-mediated neurotransmitter re-
lease. Moreover, the synergistic interaction between these recep-
tors seems to be the result of sodium influx through the NMDA
receptor channel on activation of these receptors and dopamine
D1 receptor/cAMP-mediated inhibition of the sodium pump
(preventing outward sodium transport). It should be emphasized
here that in addition to the inhibitory effect of dopamine D1
receptor activation on Na1/K1-ATPase in striatal medium spiny
neurons, dopamine D1 receptors are also known to enhance
NMDA receptor functioning through cAMP/PKA-dependent
regulation of the phosphorylation state of NMDA receptors
(Blank et al., 1997; Snyder et al., 1998). Therefore, dopamine D1
receptor-mediated phosphorylation of NMDA receptors, in ad-
dition to cAMP-dependent inhibition of the sodium pump, may
well play an additional role in the synergistic effect of dopamine
on NMDA-evoked GABA efflux and its inhibition by m-opioid
receptor activation (Fig. 9).
Although the present study indicates that G-protein-coupled
receptors, like ionotropic receptors, may modulate transmem-
brane GABA transport in striatal medium spiny neurons in a
sodium-dependent manner, additional mechanisms may play a
role in the regulation of GABA transporters by striatal neuro-
transmitters. In this respect, the functioning and internalization
of GABA (GAT 1) transporters has been shown to be regulated
by second messengers and by proteins of the so-called SNARE
complex. However, the initial triggers for this regulation are as
yet largely unknown (Beckman et al., 1998; Bernstein and
Quick, 1999).
The relative contribution of this slow neurotransmitter receptor-
regulated nonvesicular release to striatal extracellular GABA
levels in vivo can be expected to depend on the extracellular
concentrations of dopamine and glutamate as well as on the
frequency of action potentials in medium spiny neurons and their
Figure 9. Proposed mechanisms underlying NMDA-, dopamine D1-,
and m-opioid receptor-mediated modulation of calcium-independent
GABA release from rat striatal neurons. In this model, activation of
NMDA receptors causes sodium entry through the receptor channel
leading to a reduction of the electrochemical transmembrane sodium
gradient, which in turn results in reversal of the GABA transporter
mediating GABA release from the cytoplasmic pool. Activation of dopa-
mine D1 receptors increases adenylyl cyclase activity, leading to cAMP/
protein kinase A-dependent phosphorylation of Na 1/K 1-ATPase. The
resulting inhibition of sodium pump activity is assumed to cause a slow
accumulation of intracellular sodium leading to (1) reversal of the GABA
transporter causing nonvesicular GABA release and (2) potentiation of
the effect of NMDA receptor activation on the intracellular sodium
concentration. Activation of m-opioid receptors causes inhibition of
dopamine-stimulated adenylyl cyclase activity, thereby inhibiting this
effect of dopamine D1 receptor activation. A cAMP/protein kinase
A-dependent regulation of the phosphorylation of NMDA receptors,
proposed by others (Blank et al., 1997; Snyder et al., 1998), is also
included in this model because it may also play a role in the synergistic
effect of dopamine and NMDA on transporter-mediated GABA release
in addition to inhibition of sodium pump activity.
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excitatory input causing exocytotic synaptic release of GABA.
Interestingly, because amphetamine-induced transporter-mediated
GABA efflux appeared to represent ;40% of the amount of
GABA released in rat striatum in vivo (Del Arco et al., 1998), it
may be quite substantial after psychostimulant exposure associ-
ated with a sustained increase in extracellular dopamine and
glutamate levels (Kuczenski and Segal, 1989; Xue et al., 1996;
Reid et al., 1997). Recent studies indicate that dopamine D1
receptors in the striatum display a gating property that by en-
hancing sustained glutamate-induced activation GABA neurons
could play a crucial role in the behavioral activating effects of
psychostimulants (Kalivas and Nakamura, 1999). In this respect,
the synergistic interaction between dopamine D1 and NMDA
receptors shown here may be of particular interest. A sustained
increase in extracellular GABA levels reduces the excitability of
input and output neurons of the striatum, including that of
efferent GABA neurons through lateral inhibition (Groves, 1983).
Therefore, nonvesicular transporter-mediated GABA release
may contribute to the inhibitory effect of psychostimulants on the
firing rate of (subsets of) afferent and efferent striatal neurons as
demonstrated in vivo (White et al., 1993; Nicola et al., 1996). By
regulating both action potential-dependent exocytotic GABA re-
lease and transporter-mediated nonvesicular GABA efflux, dopa-
mine, glutamate, and opioids may orchestrate a pattern of acti-
vation and inhibition among striatal neurons that may be a
necessary condition for the psychomotor and rewarding effects of
drugs.
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